Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTA vs Ferric Sulfate Pulpotomies in Primary Molars
NCT02783911Terminated
- Sponsor
- Loma Linda University
- Start
- Jan 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Randomised trial of ferric sulfate in reversible pulpitis, sponsored by Loma Linda University. Primary endpoints: Clinical Success at 12 months and Radiographic Success at 12 months. Started Jan 2015; status: terminated.
02
Drugs
ferric sulfate
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT02783911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783911.